American Joint Committee on Cancer Staging System Does Not Accurately Predict Survival in Patients Receiving Multimodality Therapy for Esophageal Adenocarcinoma Over 35 months, 28 patients were ...

New guidance on managing desmoid fibromatosis recommends a more conservative approach, encompassing the patient perspective, active surveillance, tumor location, and risk-benefit assessment. Outcomes ...

Desmoid tumors, also known as aggressive fibromatosis or desmoid-type fibromatosis, are rare, generally nonmalignant, soft tissue tumors that are abnormal growths of connective tissue. The tumors are ...

New hope is available for children who have a tumor called desmoid fibromatosis, according to results of a national clinical trial that was led by a St. Jude researcher. The study found that the ...

STAMFORD, Conn., Dec. 27, 2022 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients ...

Aggressive fibromatosis (desmoid tumour) is a locally invasive tumour caused by mutations resulting in β-catenin protein stabilisation. Apc1638N mice are predisposed to developing aggressive ...

After a period of active surveillance (AS), most patients with non-intraabdominal desmoid-type fibromatosis (DTF) did not have to progress to active treatment, a researcher reported. In the GRAFITI ...

Moderate dose radiotherapy is an effective treatment for patients with such a rare type of tumor, according to a phase 2 EORTC trial for patients with inoperable desmoid-type fibromatosis. The study ...

Brooke was only three years old when she first learned about desmoid tumors. “My mother had six or seven,” she recalls. Brooke’s mother also had 28 surgeries related to her desmoid tumors and multiple ...